Till M - Search Results

1

Failure of Serial Electrocardiograms to Exclude a Large Anterior Myocardial Infarction and the Role of Transesophageal Echocardiogram in Acute Myocardial Infarction.

Wang Y, Cheirif J, Meyer S, Knochel J, Till M. Wang Y, et al. Among authors: till m. Echocardiography. 1999 Apr;16(3):263-267. doi: 10.1111/j.1540-8175.1999.tb00812.x. Echocardiography. 1999. PMID: 11175148

2

Large scale preparation of an immunoconjugate constructed with human recombinant CD4 and deglycosylated ricin A chain.

Ghetie V, Till MA, Ghetie MA, Uhr JW, Vitetta ES. Ghetie V, et al. Among authors: till ma. J Immunol Methods. 1990 Jan 24;126(1):135-41. doi: 10.1016/0022-1759(90)90021-m. J Immunol Methods. 1990. PMID: 2303721

3

Preparation and characterization of conjugates of recombinant CD4 and deglycosylated ricin A chain using different cross-linkers.

Ghetie V, Till MA, Ghetie MA, Tucker T, Porter J, Patzer EJ, Richardson JA, Uhr JW, Vitetta ES. Ghetie V, et al. Among authors: till ma. Bioconjug Chem. 1990 Jan-Feb;1(1):24-31. doi: 10.1021/bc00001a003. Bioconjug Chem. 1990. PMID: 2095203

4

Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain.

Till MA, Zolla-Pazner S, Gorny MK, Patton JS, Uhr JW, Vitetta ES. Till MA, et al. Proc Natl Acad Sci U S A. 1989 Mar;86(6):1987-91. doi: 10.1073/pnas.86.6.1987. Proc Natl Acad Sci U S A. 1989. PMID: 2538826 Free PMC article.

5

Monoclonal antibodies as carriers of toxins.

Uhr JW, Fulton RJ, Till MA, May RD, Vitetta ES. Uhr JW, et al. Among authors: till ma. Prog Clin Biol Res. 1989;288:403-12. Prog Clin Biol Res. 1989. PMID: 2785694 No abstract available.

6

HIV-infected cells are killed by rCD4-ricin A chain.

Till MA, Ghetie V, Gregory T, Patzer EJ, Porter JP, Uhr JW, Capon DJ, Vitetta ES. Till MA, et al. Science. 1988 Nov 25;242(4882):1166-8. doi: 10.1126/science.2847316. Science. 1988. PMID: 2847316

7

Redesigning nature's poisons to create anti-tumor reagents.

Vitetta ES, Fulton RJ, May RD, Till M, Uhr JW. Vitetta ES, et al. Among authors: till m. Science. 1987 Nov 20;238(4830):1098-104. doi: 10.1126/science.3317828. Science. 1987. PMID: 3317828 Review.

8

Phase I immunotoxin trial in patients with B-cell lymphoma.

Vitetta ES, Stone M, Amlot P, Fay J, May R, Till M, Newman J, Clark P, Collins R, Cunningham D, et al. Vitetta ES, et al. Among authors: till m. Cancer Res. 1991 Aug 1;51(15):4052-8. Cancer Res. 1991. PMID: 1855219 Clinical Trial.

9

Immunoconjugates containing ricin A chain and either human anti-gp41 or CD4 kill H9 cells infected with different isolates of HIV, but do not inhibit normal T or B cell function.

Till MA, Ghetie V, May RD, Auerbach PC, Zolla-Pazner S, Gorny MK, Gregory T, Uhr JW, Vitetta ES. Till MA, et al. J Acquir Immune Defic Syndr (1988). 1990;3(6):609-14. J Acquir Immune Defic Syndr (1988). 1990. PMID: 2140127

10

Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.

Ghetie MA, May RD, Till M, Uhr JW, Ghetie V, Knowles PP, Relf M, Brown A, Wallace PM, Janossy G, et al. Ghetie MA, et al. Among authors: till m. Cancer Res. 1988 May 1;48(9):2610-7. Cancer Res. 1988. PMID: 2451562 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

256 results

Search Page